Madrigal Pharmaceuticals is a trailblazing biopharmaceutical company dedicated to transforming the lives of patients suffering from metabolic dysfunction-associated steatohepatitis (MASH). Driven by a mission to improve standards of care, Madrigal leverages deep scientific expertise and operational rigor to bring transformative therapies from the laboratory to the clinic.
Beyond their medical achievements, the company is recognized for its unique corporate culture. By providing company-wide equity, Madrigal ensures that every employee feels a direct sense of ownership and accountability. With a collaborative, inclusive, and high-performance environment, the company offers a compelling mission for professionals looking to make a meaningful impact in the biopharmaceutical industry.